Achieve More with Intuitive 340B Solutions

learn more

Comprehensive 340BPlus Solutions

Split Billing

Provides fully customizable, end-to-end 340B program management with a focus on program compliance.

learn more


A comprehensive self-audit solution to streamline workflow, quickly identify errors and omissions and implement processes to ensure 340B program compliance.

learn more

Contract Pharmacy

Our network helps to ensure 340B eligible patient compliance and access to competitively priced prescriptions.

learn more

The RxStrategies Difference

Integrated solutions that assist providers in meeting the challenges of maintaining a compliant 340B Drug Pricing Program.

View our 340B Solutions

Clinical Insights: April 1, 2020

Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Zeposia® (ozanimod) Capsules – New Drug Approval – March 26, 2020 – Bristol-Myers Squibb Company announced that the U.S. Food and Drug Administration (FDA) approved Zeposia® (ozanimod) 0.92… Read more »


Connect with RxStrategies at the 2020 Policy & Issues Forum

  RxStrategies representatives, Rhodie Smith and Todd Hudnall will attend the 2020 Policy & Issues Forum (P&I Forum), March 16 – 19, in Washington, DC. Hosted by the National Association of Community Health Centers (NACHC), the P&I Forum is one of the largest conferences focused on primary care and health policy. The event brings together… Read more »